Highly significant enrichment was observed for the hallmark “ROS pathway” in the transcriptomic analysis ( Figure 1 A-B ).
← all excerpts
Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5.
1
—
—